Standards Development for Regenerative Medicine Therapies

Inactive
Notice ID:FDA-SSN-1224405

Standards Development for Regenerative Medicine Therapies, per the attached source sought notice FDA-SSN-1224405.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   OTHER SPECIAL STUDIES AND ANALYSES
LOCATION:

Links ()

Attachments ()


Data sourced from SAM.gov. View Official Posting »